Telehealth Program Tested in Infant Siblings of Autistic Children
Tests a telehealth parent-coaching program in infants and toddlers with autistic siblings.
Plain-language title generated from the registry record
Registry title: Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children
Key facts
- Where
- Austin and Nashville, United StatesSee the 2 sites
Where in United States
- Little Longhorn LabAustin, United StatesTaking people
- VUMCNashville, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Texas at Austin
- Trial code
- NCT07069413
- Record updated
- 12 June 2026
- Original description
This rigorous randomized controlled trial will evaluate the efficacy and acceptability of a preemptive, telehealth intervention (tele-ImPACT) in a large, representative sample of infant siblings of autistic children, who are known to be at high likelihood of receiving a future diagnosis of autism and/or developmental language disorder (HL-Sibs). If our hypotheses are supported, this innovative and interdisciplinary study will provide empirical support for a novel approach to treatment that is theoretically motivated and developmentally informed, as well as accessible for and acceptable to families, and will lend new insights into the developmental windows in which, mechanisms by which, and subgroups for which the treatment works. Such findings would have strong implications for research, policy, theory, and practice in young children at risk for autism and/or language disorder.Read full original descriptionShow less
Sibwatch: Optimizing Intervention Options for Infants and Toddlers With a High Likelihood of Social Communication Delays and Language Disorder
This rigorous randomized controlled trial will evaluate the efficacy and acceptability of a preemptive, telehealth intervention (tele-ImPACT) in a large, representative sample of infant siblings of autistic children, who are known to be at high likelihood of receiving a future diagnosis of autism and/or developmental language disorder (HL-Sibs). If our hypotheses are supported, this innovative and interdisciplinary study will provide empirical support for a novel approach to treatment that is theoretically motivated and developmentally informed, as well as accessible for and acceptable to families, and will lend new insights into the developmental windows in which, mechanisms by which, and subgroups for which the treatment works. Such findings would have strong implications for research, policy, theory, and practice in young children at risk for autism and/or language disorder.
Inclusion: chronological age between 6-24 months; has at least one older biological sibling diagnosed with autism.
Exclusion: primary sensory deficit (hearing or visual impairment); adverse neurological history; pre-term birth (gestation <37 weeks); pre-existing diagnosis of autism or language delay.